Latest Blog Entries

Smiths Medical Searching for New CEO while Demerging from Smiths Group

Smiths Medical Searching for New CEO while Demerging from Smiths Group

March 28, 2019

Smiths Medical is searching for a new CEO to lead its impending transition from subsidiary of Smiths Group to a free-standing publicly traded company by July 2020.

B. Braun Syringe Pump Includes Air and Road Transport in FDA 510(K) Indications for Use

B. Braun Syringe Pump Includes Air and Road Transport in FDA 510(K) Indications for Use

June 26, 2018

B.Braun Medical received FDA Clearance for air and road transport for the Perfusor® Space 2nd Generation Syringe Pump.

Baxter’s New Spectrum IQ Infusion System Cleared by U.S. FDA

Baxter’s New Spectrum IQ Infusion System Cleared by U.S. FDA

May 24, 2018

Baxter International announced the U.S. FDA clearance of the Spectrum IQ System with Dose IQ Safety Software.

FDA Turns Down Industry Call for Regulatory Controls on Third-Party Medical Device Servicers

FDA Turns Down Industry Call for Regulatory Controls on Third-Party Medical Device Servicers

May 24, 2018

In a long-awaited report, the FDA states it does not believe there is a safety problem with the servicing, manufacturing, and repair of medical devices by third-party organizations or the original equipment manufacturers.

Hospitals Still Suffering From Hurricane Damage in Puerto Rico

Hospitals Still Suffering From Hurricane Damage in Puerto Rico

January 11, 2018

Hurricanes Harvey, Irma, and Maria caused major damage to Baxter International’s plants in Puerto Rico leaving the U.S with a nationwide shortage of saline intravenous bags. Because hospitals can go through hundreds or thousands of IV bags a day, they have had to consider halting clinical trials and delaying elective procedures.

Preventing Dosing Errors in High-Risk Infusions Due to Titration Programming

Preventing Dosing Errors in High-Risk Infusions Due to Titration Programming

December 14, 2017

Baxter Healthcare Corporation affiliated authors conducted a study of harmful dosing changes caused by titration miss-programming. The study was presented at the 2017 ASHP Midyear Clinical Meeting and Exhibition.

[12 3 4 5  >>  

Shopping Cart (for )

 x 
Cart empty
×
×

Test Abandone Pop-up Box

×

Welcome Back
Customer

We saved your cart from your last visit. Do you want to pick back up where you left off?